Ensho Therapeutics is a clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory bowel disease, particularly through its portfolio of oral α4β7 integrin inhibitors
Ensho Therapeutics is a clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory bowel disease, particularly through its portfolio of oral α4β7 integrin inhibitors.